Selective cytostatic and cytotoxic effects of glucosinolates hydrolysis products on human colon cancer cells in vitro

Anti-Cancer Drugs

Volumn 9, Issue 2, 1998, Pages 141-148

  Gamet Payrastre, Laurence ^a   Lumeau, Solange ^a   Gasc, Nicole ^a   Cassar, Georges ^b   Rollin, Patrick ^c   Tulliez, Jacques ^a  

^a CEMAGREF   (France)

^b CHU PURPAN   (France)

^c UNIVERSITÉ D'ORLÉANS   (France)

Author keywords

Colon carcinoma cells; Cruciferous vegetable; Diindolylmethane; Glucosinolate; HT29 cells; Sulforaphane

Indexed keywords

DIINDOLYLMETHANE; GLUCOBRASSICIN; GLUCORAPHANIN; GLUCOSINOLATE; SULFORAPHANE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL DIFFERENTIATION; CELL STRAIN CACO 2; CELL STRAIN HT29; CELL VIABILITY; COLON CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSTASIS; CYTOTOXICITY; HUMAN; HUMAN CELL; HYDROLYSIS; PRIORITY JOURNAL; VEGETABLE;

EID: 0031939472     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199802000-00005     Document Type: Article

References (29)

1. Block G, Patterson, B, Subar, A. Fruit, vegetables and cancer prevention: a review of the epidemiological evidence. Nutr Cancer 1992; 18: 1-29.
2. Walker R. Modulation of toxicity by dietary and environmental factors. Environ Toxicol Pharmacol 1996; 2: 181-8.
3. Fenwick GR, Heaney RK. Glucosinolates and their breakdown products in cruciferous crops, foods and feedingstuffs. Food Chem 1983; 11: 249-71.
4. Hill CB, Williams PH, Carlson DG, Tookey HL. Variation in glucosinolates in oriental brassica vegetables. J Am Soc Hort Sci 1987; 112: 309-13.
5. McDanell R, McLean AEM, Hanley AB, Heaney RK, Fenwick GR. Chemical and biological properties of indole glucosinolates (glucobrassicins): a review. Food Chem Toxicol 1988; 26: 59-70.
6. Hecht SS. Chemoprevention by isothiocyanates. J Cell Biochem 1995; 22: 195-209.
7. Verhoeven DTH, Verhagen H, Goldbohm RA, van der Brandt PA, van Poppel G. A Review of mechanisms underlying anticarcinogenicity by brassica vegetables. Chem-Biol Interact 1997; 103: 79-129.
8. Talalay P, Zhang Y. Chemoprevention against cancer by isothiocyanates and glucosinolates. Biochem Soc Trans 1996; 24: 806-10.
9. 2/M phase. Anti-cancer Drugs 1993; 4: 273-9.
10. Tiwari RK, Guo L, Bradlow L, Telang NT, Osborne MP. Selective responsiveness of human breast cancer cells to indole-3-carbinol, a chemopreventive agent. J Nat Cancer Inst 1994; 86: 126-31.
11. Ge X, Yannai S, Rennert G, Gruener N, Fares FA. 3,3′-Diindolylmethane induces apoptosis in human cancer cells. Biochem Biophys Res Commun 1996; 228: 153-8.
12. Nastruzzi C, Cortesi R, Esposito E, et al. In vitro cytotoxic activity of some glucosinolate-derived products generated by myrosinase hydrolysis. J Agric Food Chem 1996; 44: 1014-21.
13. Zweibaum A, Laburthe M, Grasset E, Louvard D. Use of cultured cell lines in studies of intestinal cell differentiation and function In: Fieldand M, Frizzel RA, eds. Handbook of physiology: the gastrointestinal system. Intestinal absorption and secretion. Bethesda, MD: American Physiology Society 1991: 223-35.
14. Viaud MG, Rollin P. First synthesis of an indole glucosinolate. Tetrahedron Lett 1990; 31: 1417-8.
15. Schmid H, Karrer P. Synthese der racemischen und der optiscch aktiven Formen des sulforaphans. Helv Chim Acta 1948; 31: 1497.
16. Leete E, Marion L. The hydrogenolysis of 3-hydroxymethylindole and other indole derivates with lithium aluminium hydride. Can J Chem 1953; 31: 775-84.
17. Latxague L, Gardrat C, Coustille JL, Viaud MC, Rollin P. Identification of enzymatic degradation products from synthesized glucobrassicin by gas chromatography-mass spectrometry. J Chromatogr 1991; 586: 166-70.
18. Fogh J, Fogh JN, Orfeo T. One hundred and twenty seven cultured human tumor cell lines producing tumors in nude mice. J Natl Cancer Inst 1977; 59: 221-6.
19. Husoy T, Syverson T, Jenssen J. Comparison of four in vitro cytotoxicity tests: the MTT assay, NR assay, uridine incorporation and protein measurements. Toxicol In Vitro 1993; 7: 149-54.
20. Vindelov LC, Christensen IJ. A review of techniques and results obtained in one laboratory by an integrated system of methods designed for routine clinical flow cytometric DNA analysis. Cytometry 1990; 11: 753-70.
21. Grubbs CJ, Steele VE, Casebolt T, et al. Chemoprevention of chemically-induced mammary carcinogenesis by indole-3-carbinol. Anticancer Res 1995; 15: 709-16.
22. Dashwood RH, Fong AT, Arbogast DN, Bjeldanes LF, Hendricks JD, Bayley GS. Anticarcinogenic activity of indole-3-carbinol acid products: ultrasensitive bioassay by trout embryo microinjection. Cancer Res 1994; 54: 3617-9.
23. Bradfield CA, Bjeldanes LF. Structure activity relationships of dietary indoles: a proposed mechanism of action as modifiers of xenobiotics metabolism. J Toxicol Environ Health 1987; 21: 311-23.
24. Zhang Y, Talalay F. Anticarcinogenic activities of organic isothiocyanates: chemistry and mechanisms. Cancer Res 1994; 54: 1976S-81S.
25. Zhang Y, Kensler TW, Cho CG, Posner GH, Talalay P. Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates. Proc Natl Acad Sci USA 1994; 91: 3147-50.
26. Barcelo S, Gardiner JM, Gescher A, Chipman JK. CYP2E1 mediated mechanism of anticarcinogenicity of broccoli constituant sulforaphane. Carcinogenesis 1996; 17: 277-82.
27. Reynier M, Sari H, d'Anglebermes M, Ah Kaye E, Pasero L. Differences in lipid characteristics of undifferentiated and enterocytic differentiated HT29 human colonic cells. Cancer Res 1991; 51: 1270-7.
28. Temmink JHM, Bruggeman IM, van Bladeren, PJ. Cytomorphological changes in liver cells exposed to allyl and benzyl isothiocyanate and their cysteine and glutathione conjugates. Arch Toxicol 1986; 59: 103-10.
29. Musk SRR, Stephenson P, Smith TK, Stening P, Fyfe D, Jonhson IT. Selective toxicity of compounds naturally present in food toward the transformed phenotype of human colorectal cell line HT29. Nutr Cancer 1995; 24: 289-98.